Prostap Depot 11,25 mg pulver og solvens til injektionsvæske, suspension, fyldt injektionssprøjte ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

prostap depot 11,25 mg pulver og solvens til injektionsvæske, suspension, fyldt injektionssprøjte

paranova danmark a/s - leuprorelinacetat - pulver og solvens til injektionsvæske, suspension, fyldt injektionssprøjte - 11,25 mg

Degarelix Accord ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

degarelix accord

accord healthcare s.l.u. - degarelix acetate - prostatiske neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Firmagon ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostatiske neoplasmer - endokrine terapi - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.